Advocacy / Projects

3rd Health Programme (2014-2020)
Stronger Together [AAE]
“Stronger together” is the title of this proposal of AIDS Action Europe (AAE), a network of 415 NGOs, national networks, AIDS service organisations, and community based groups in 47 countries in ...
“Stronger together” is the title of this proposal of AIDS Action Europe (AAE), a network of 415 NGOs, national networks, AIDS service organisations, and community based groups in 47 countries in the WHO European Region. The motto reflects the objective of AAE to join efforts, not only within the network but also with other stakeholders and partners in the response to HIV/AIDS, tuberculosis and viral hepatitis. In April 2017, the AAE Steering Committee decided to change its mission statement: The integrative approach, addressing not only HIV/AIDS but also tuberculosis and viral hepatitis as mono-infections, echoes the decision to use synergies and avoid duplications wherever and whenever possible. This applies in particular for key populations who are especially affected by and vulnerable to the three epidemics.
But “Stronger together” also stands for maintaining and improving collaboration and communication between partners in the 3rd Health programme in the field of HIV/AIDS, TB and viral hepatitis as well as for ensuring sustainability of materials and deliverables developed within the programme.
Considering the epidemiological background of the three diseases and AAE’s mission, vision and strategy and after consulting AAE Members and partners, the following six core thematic areas were identified to focus on in the upcoming four years:
- Community based voluntary counselling and testing (CBVCT)
- Affordability and accessibility to medicines
- Tackling legal barriers in the response to HIV, TB and hepatitis
- Criminalisation of HIV non-disclosure, exposure and transmission
- Sexual and reproductive health and rights (SRHR)
- Tackling stigma and discrimination
The three main objectives of the work are
- advocacy to strengthen Civil Society’s response to the three epidemics,
- providing platforms to communicate and facilitate collaboration, networking, and linking and learning
- and continuous improvement of network collaboration.

Start date: 30/01/2018 - End date: 29/01/2022

Call: Operating grants 2018-2021
Topic: Advocacy
3rd Health Programme (2014-2020)
Correlation Network on Harm Reduction and Social Inclusion [CN]
The Correlation Network (CN) is a European civil society network and centre of expertise in the field of drug use, harm reduction and social inclusion.

Overall objective of this proposal:
Improve th...
The Correlation Network (CN) is a European civil society network and centre of expertise in the field of drug use, harm reduction and social inclusion.

Overall objective of this proposal:
Improve the access to and the quality of harm reduction services for People Who Use Drugs (PWUD), including other related vulnerable and marginalised people and to enhance policies and practices that increase social inclusion.

This is achieved by the following strategic objectives
- Strengthen the network and the collaboration with its members and partners through an adequate and solid organisational network structure
- Monitor developments and collect information and evidence in the field of drug use and harm reduction, by involving the expertise of civil society organisations
- Strengthen capacities of the various players in the field of drug use and harm reduction and facilitate exchange between network members and partners
- Advocate for full coverage of harm reduction programmes in Europe, addressing both health and social aspects.

All CN activities will pay specific attention to Hepatitis C, new drug trends and drug patterns and overdose prevention. Relevant CN outputs include : Sustainable network, Annual Monitoring Reports, Online knowledge and training hub, European Harm Reduction Conferences (2018/20), policy recommendations.

CN contributes to the Third Health Programme (THP) by promoting health (in particular harm reduction), prevent diseases (in particular drug-related diseases and infectious diseases such as HCV and HIV/AIDS), and foster supportive environments for healthy lifestyles (e.g. by reducing barriers to access health and social services).

CN contributes as well to the following THP priorities:
1.2. Drugs-related health damage, including information and prevention
1.3. HIV/AIDS, tuberculosis and hepatitis
2.2. Capacity-building against health threats in Member States, including, where appropriate, cooperation with
neighbouring countries



Start date: 30/01/2018 - End date: 29/01/2022

Call: Operating grants 2018-2021
Topic: Advocacy